Nektar Therapeutics Market Cap History



Below is a table of the Nektar Therapeutics market cap history going back to 2/26/2010:

Date NKTR Market Cap
2/26/20101.16B
4/30/20101.31B
7/23/20101.21B
10/31/20101.37B
2/25/20111.11B
4/25/20111.12B
8/1/2011716.26M
10/31/2011620.19M
2/24/2012799.42M
4/27/2012901.99M
8/6/2012975.58M
11/5/20121.04B
2/21/20131.04B
4/30/20131.25B
8/1/20131.47B
10/31/20131.10B
2/20/20141.74B
4/30/20141.49B
7/24/20141.40B
10/30/20141.80B
2/20/20151.79B
4/23/20151.45B
7/30/20151.63B
10/29/20151.59B
2/19/20161.55B
4/27/20162.21B
7/28/20162.20B
10/27/20161.87B
2/24/20172.07B
5/4/20172.88B
8/3/20173.13B
11/2/20173.71B
2/22/201814.20B
5/3/201814.18B
8/3/20189.30B
11/1/20187.04B
2/22/20196.97B
5/1/20195.52B
8/1/20195.47B
11/1/20193.22B
2/19/20204.06B
5/1/20203.21B
7/31/20203.96B
10/30/20202.84B
2/17/20214.64B
4/30/20213.58B
7/30/20212.90B
10/29/20212.80B
2/23/20221.82B
4/29/2022769.31M
7/29/2022742.12M
10/27/2022687.91M
2/21/2023535.54M
5/2/2023143.82M
8/1/202398.86M
10/31/202389.66M
2/27/2024137.71M

Also see: NKTR Shares Outstanding History
and NKTR YTD Return
Nektar Therapeutics Historical Market Cap:
-14.11% CAGR
Nektar Therapeutics Historical Market Cap: +-14.11% CAGR

Mouse over chart for data details
2/26/2010 ...2/27/2024
Nektar Therapeutics is a research-based biopharmaceutical company. Co.'s research and development pipeline of investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, Co. is studying several immuno-oncology drug candidates including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, Co. is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, Co.'s programs include studying bempegaldesleukin in treating individuals affected with COVID-19, and a preclinical research collaboration with Gilead Sciences Inc. to test the combination of NKTR-255. We show 57 historical shares outstanding datapoints in our NKTR shares outstanding history coverage, used to compute NKTR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing Nektar Therapeutics market cap history over the course of time is important for investors interested in comparing Nektar Therapeutics's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of Nektar Therapeutics versus a peer is one thing; comparing Nektar Therapeutics market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like Nektar Therapeutics can fluctuate over the course of history. With this page we aim to empower investors researching Nektar Therapeutics by allowing them to research the Nektar Therapeutics market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NKTR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nektar Therapeutics (NKTR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NKTX Market Cap History
NLNK Market Cap History
NLTX Market Cap History
NMRA Market Cap History
NMRD Market Cap History
NMTC Market Cap History
NMTR Market Cap History
NOTV Market Cap History
NOVN Market Cap History
NPCE Market Cap History
More Healthcare companies »

 

Nektar Therapeutics Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.